<html>
<head>PUBMED IDs for XEDAR</head>
<body bgcolor='#C5F0F2'><h1>XEDAR</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11039935/'>Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors.</a> October 20  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12084975/'>Recent advances in understanding of the molecular basis of anhidrotic ectodermal dysplasia: discovery of a ligand, ectodysplasin A and its two receptors.</a> June 27  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12270937/'>Role of TRAF3 and -6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptor.</a> September 25  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12692542/'>Permanent correction of an inherited ectodermal dysplasia with recombinant EDA.</a> April 15  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12917689/'>CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.</a> August 15  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14656435/'>The crystal structures of EDA-A1 and EDA-A2: splice variants with distinct receptor specificity.</a> December 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14656416/'>Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia.</a> December 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14749376/'>Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency.</a> January 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15294294/'>High level production and one-step purification of biologically active ectodysplasin A1 and A2 immunoadhesins using the baculovirus/insect cell expression system.</a> August 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16423472/'>Repertoire of mouse ectodysplasin-A (EDA-A) isoforms.</a> January 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18304980/'>Conserved features and evolutionary shifts of the EDA signaling pathway involved in vertebrate skin appendage development.</a> February 29  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18304967/'>EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.</a> February 29  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19543321/'>XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway.</a> September 9  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20501644/'>Crosstalk of EDA-A2/XEDAR in the p53 signaling pathway.</a> January 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20501625/'>A phase I study of 5-fluorouracil/leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma.</a> August 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/26260321/'>XEDAR activates the non-canonical NF-κB pathway.</a> November 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26659383/'>X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjögren's syndrome.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26659373/'>T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.</a> March 22  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26659366/'>Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma.</a> May 18  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26659358/'>Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts.</a> June 23  2015<br></body></html>
